|
1
|
Vokalova L, van Breda SV, Ye XL, Huhn EA,
Than NG, Hasler P, Lapaire O, Hoesli I, Rossi SW and Hahn S:
Excessive neutrophil activity in gestational diabetes mellitus:
Could it contribute to the development of preeclampsia? Front
Endocrinol (Lausanne). 9:5422018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schaefer-Graf U, Napoli A and Nolan CJ;
Diabetic Pregnancy Study Group, : Diabetes in pregnancy: A new
decade of challenges ahead. Diabetologia. 61:1012–1021.
2018.PubMed/NCBI
|
|
3
|
Damm P, Houshmand-Oeregaard A, Kelstrup L,
Lauenborg J, Mathiesen ER and Clausen TD: Gestational diabetes
mellitus and long-term consequences for mother and offspring: A
view from Denmark. Diabetologia. 59:1396–1399. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sweeting AN, Ross GP, Hyett J, Molyneaux
L, Constantino M, Harding AJ and Wong J: Gestational diabetes
mellitus in early pregnancy: Evidence for poor pregnancy outcomes
despite treatment. Diabetes Care. 39:75–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pantham P, Aye IL and Powell TL:
Inflammation in maternal obesity and gestational diabetes mellitus.
Placenta. 36:709–715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Powe CE, Allard C, Battista MC, Doyon M,
Bouchard L, Ecker JL, Perron P, Florez JC, Thadhani R and Hivert
MF: Heterogeneous contribution of insulin sensitivity and secretion
defects to gestational diabetes mellitus. Diabetes Care.
39:1052–1055. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Du J, Zhu YL and Gao XM: Expressions of
inflammatory cytokines and fat factors in placentas of patients
with gestational diabetes mellitus and their relationship with
glucose and lipid metabolism. Hainan Yixueyuan Xuebao. 22:39–42.
2016.(In Chinese).
|
|
8
|
Mariani F and Roncucci L: Chemerin/chemR23
axis in inflammation onset and resolution. Inflamm Res. 64:85–95.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kennedy AJ and Davenport AP: International
union of basic and clinical pharmacology CIII: Chemerin receptors
CMKLR1 (Chemerin1) and GPR1 (Chemerin2) nomenclature, pharmacology,
and function. Pharmacol Rev. 70:174–196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haberl EM, Pohl R, Rein-Fischboeck L,
Feder S, Eisinger K, Krautbauer S, Sinal CJ and Buechler C: Ex vivo
analysis of serum chemerin activity in murine models of obesity.
Cytokine. 104:42–45. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cetin O, Kurdoglu Z, Kurdoglu M and Sahin
HG: Chemerin level in pregnancies complicated by preeclampsia and
its relation with disease severity and neonatal outcomes. J Obstet
Gynaecol. 37:195–199. 2017.PubMed/NCBI
|
|
12
|
Yang X, Quan X, Lan Y, Wei Q, Ye J, Yin X,
Ji Z, Xing H and Yang Y: Serum chemerin level in women with PCOS
and its relation with the risk of spontaneous abortion. Gynecol
Endocrinol. 34:864–867. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ademoglu E, Berberoglu Z, Dellal FD and
Ariel KM: Higher levels of circulating chemerin in obese women with
gestational diabetes mellitus. Acta Endocrinol (Bucur).
11:1841–0987. 2015.
|
|
14
|
Yang X, Quan X, Lan Y, Ye J, Wei Q, Yin X,
Fan F and Xing H: Serum chemerin level during the first trimester
of pregnancy and the risk of gestational diabetes mellitus. Gynecol
Endocrinol. 33:770–773. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guaita-Esteruelas S, Gumà J, Masana L and
Borràs J: The peritumoural adipose tissue microenvironment and
cancer. The roles of fatty acid binding protein 4 and fatty acid
binding protein 5. Mol Cell Endocrinol. 462:107–118. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hertzel AV, Xu H, Downey M, Kvalheim N and
Bernlohr DA: Fatty acid binding protein 4/aP2-dependent BLT1R
expression and signaling. J Lipid Res. 58:1354–1361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ning H, Tao H, Weng Z and Zhao X: Plasma
fatty acid-binding protein 4 (FABP4) as a novel biomarker to
predict gestational diabetes mellitus. Acta Diabetol. 53:891–898.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Gennaro G, Palla G, Battini L,
Simoncini T, Del Prato S, Bertolotto A and Bianchi C: The role of
adipokines in the pathogenesis of gestational diabetes mellitus.
Gynecol Endocrinol. 35:737–751. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
American Diabetes Association:
Classification and diagnosis of diabetes. Diabetes Care. 40 (Suppl
1):S11–S24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang L, Rissin DM, Fournier DR, Piech T,
Patel PP, Wilson DH and Duffy DC: Single molecule enzyme-linked
immunosorbent assays: theoretical considerations. J Immunol
Methods. 378:102–115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Z, Gong L, Zhang P, Li Y, Liu B,
Zhang L, Zhuang J and Xiao D: Epigenetic down-regulation of Sirt 1
via DNA methylation and oxidative stress signaling contributes to
the gestational diabetes mellitus-induced fetal programming of
heart ischemia-sensitive phenotype in late life. Int J Biol Sci.
15:1240–1251. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Muller PS and Nirmala M: Effects of pre
pregnancy maternal body mass index on gestational diabetes
mellitus. IACSIT Int J Eng Technol. 7:279–282. 2018. View Article : Google Scholar
|
|
23
|
Gilbert L, Gross J, Lanzi S, Quansah DY,
Puder J and Horsch A: How diet, physical activity and psychosocial
well-being interact in women with gestational diabetes mellitus: An
integrative review. BMC Pregnancy Childbirth. 19:602019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Artal R, Catanzaro RB, Gavard JA, Mostello
DJ and Friganza JC: A lifestyle intervention of weight-gain
restriction: diet and exercise in obese women with gestational
diabetes mellitus. Appl Physiol Nutr Metab. 32:596–601. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roca-Rodríguez MM, López-Tinoco C,
Fernández-Deudero A, Murri M, García-Palacios MV, García-Valero MA,
Tinahones-Madueño FJ and Aguilar-Diosdado M: Adipokines and
metabolic syndrome risk factors in women with previous gestational
diabetes mellitus. Diabetes Metab Res Rev. 28:542–548. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang J, Chi H, Xiao H, Tian X, Wang Y,
Yun X and Xu Y: Interleukin-6 (IL-6) and tumor necrosis factor-α
(TNF-α) single nucleotide polymorphisms (SNPs), inflammation and
metabolism in gestational diabetes mellitus in Inner Mongolia. Med
Sci Monit. 23:4149–4157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Melekoglu R, Ciftci O, Celik E, Yilmaz E
and Bastemur AG: Evaluation of second trimester amniotic fluid
ADAMTS4, ADAMTS5, interleukin-6 and tumor necrosis factor-α levels
in patients with gestational diabetes mellitus. J Obstet Gynaecol
Res. 45:824–829. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feng Y, Jiang CD, Chang AM, Shi Y, Gao J,
Zhu L and Zhang Z: Interactions among insulin resistance,
inflammation factors, obesity-related gene polymorphisms,
environmental risk factors, and diet in the development of
gestational diabetes mellitus. J Matern Fetal Neonatal Med.
32:339–347. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chung JY, Ain QU, Song Y, Yong SB and Kim
YH: Targeted delivery of CRISPR interference system against Fabp4
to white adipocytes ameliorates obesity, inflammation, hepatic
steatosis, and insulin resistance. Genome Res. 29:1442–1452. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Josephrajan A, Hertzel AV, Bohm EK,
McBurney MW, Imai SI, Mashek DG, Kim DH and Bernlohr DA:
Unconventional secretion of adipocyte fatty acid binding protein
(FABP4) by adipocytes. FASEB J. 32:814.11. 2018.
|
